Could two doses of a dialysis fluid help Kids' hearts and kidneys?
NCT ID NCT07168343
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether using two daily exchanges of a special dialysis fluid called icodextrin can better control fluid buildup and blood pressure in children on chronic peritoneal dialysis. Ten children aged 5-18 will be enrolled. The goal is to see if this approach improves fluid removal and reduces the need for blood pressure medications, while also checking if it adds extra burden on caregivers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- icodextrin
- What this could lead to
- If it works, this could point toward a better way to manage fluid overload and blood pressure in children on dialysis, potentially reducing hospital visits.
- What could go wrong
- This is a very small, early trial with only 10 children. The added exchange may increase caregiver burden and might not improve outcomes. Results may not apply to all children on dialysis.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHILDREN ON CHRONIC PERITONEAL DIALYSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National University Hospital
Singapore, Singapore
More trials for these conditions
Other studies related to the condition(s) this trial covers.